Ignite Creation Date:
2025-12-25 @ 2:18 AM
Ignite Modification Date:
2025-12-31 @ 11:01 AM
Study NCT ID:
NCT02710734
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-12-24
First Post:
2016-02-18
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Risk Enabled Therapy After Initiating Neoadjuvant Chemotherapy for Bladder Cancer (RETAIN)
Sponsor:
Fox Chase Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-02-24
Start Date Type:
ACTUAL
Primary Completion Date:
2027-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2034-02
Completion Date Type:
ESTIMATED
First Submit Date:
2016-02-18
First Submit QC Date:
None
Study First Post Date:
2016-03-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-12-20
Last Update Post Date:
2024-12-24
Last Update Post Date Type:
ACTUAL